Posts by Sandra Ansanay-Alex
Venture Technology Connect
Apply for Venture Technology Connect and go to Verbier next November to pitch you project to a selected audience of investors Swiss start-ups are seeking for capital to fuel their growth. And investors want to invest their money intelligently, according to their values and preferences. Venture Technology Connect is coming to the Verbier region for…
Read MoreEPFL Innogrants
Five EPFL-based life sciences startups, Alpion CryoSolutions, Eleum, Feedback Intuitive, MOLECL, and NourishAI are the latest recipients of the EPFL Startup Launchpad Innogrant and Innogrant for biotherapeuthics. Each team has secured CHF 100,000 to accelerate the development of their technology. Alpion CryoSolutions Cryo-electron microscopy has transformed biology by allowing researchers to see proteins in extraordinary detail. However, existing…
Read MoreAC Immune and Eli Lilly Sign New Agreement Worth CHF 10 Million
Eli Lilly has handed Vaud-based AC Immune (Switzerland) 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC Immune in a 2018 deal that included an $81 million upfront fee. That pact, which came with up to 1.7 billion francs ($2.1 billion)…
Read MoreTerapet Launches FLASHVIVO to Enable Real-Time Verification in FLASH Therapy
Gevena-based start-up and CERN spinoff Terapet SA has announced the launch of FLASHVIVO, a new collaborative research and development project designed to tackle one of the most critical challenges facing the clinical adoption of FLASH radiotherapy: the lack of real-time, in vivo treatment verification under ultra-high dose rate conditions. FLASH radiotherapy has emerged as a…
Read MoreSMART Challenge
The SMART Challenge 2026 kicks off on 21 April 2026 —and it needs concrete, innovative ideas to make physical activity more accessible, more appealing, and above all… easier to incorporate into daily life. Are you an entrepreneur, a student, a healthcare professional, or simply someone with an impactful idea that needs to be tested in…
Read MoreOculis Announces European Medicines Agency PRIME Designation for Privosegtor
Oculis Holding AG, based in canton of Vaud and Zug, has received a significant regulatory boost for its neuroprotective candidate Privosegtor, with the European Medicines Agency (EMA) granting the therapy Priority Medicines (PRIME) designation for the treatment of optic neuritis (ON). Optic neuritis is a rare and sight-threatening condition that can occur as a relapse…
Read MoreStarting up in Women’s Health
Starting up in Women’s Health is taking place on 23 April 2026 at Sitem-Insel in Bern Women’s health is entering a new era of innovation—driven by advances in gender medicine, digital technologies, and entrepreneurial potential. This seminar brings together experts from research, clinical practice, digital health, and venture capital to explore how scientific insights can be…
Read MoreAge Innovation Prize
Apply before 14 June 2026 for the Age Innovation Prize of the Institute for Ageing Research IAF in partnership with the Age-Stiftung. This Switzerland-wide competition promotes innovative ideas that deal with the challenges of age(ing). It honours innovative technological (AgeTech) and social projects that promote the independence, social inclusion, quality of life and health of…
Read MoreValorization Award 2026
Join the Knowledge Transfer UNIL CHUV for the VALORIZATION AWARD 2026 on 11 june 2026 at Biopôle Campus from 4 PM. This event will bring together experts and professionals from both the public and private sectors to share their insights, experiences, and perspectives on transforming research into tangible value. Speakers 📆 11 June 2026 |…
Read MoreBIND 2026 Crowns Four Life Sciences Winners
Four Swiss Health Gems won several awards during BIND – BioInnovation Day 2026. Dexterous Endoscope won the Best Start-Up Award, PreciMune got the Best Academic Project Award. Impli AG and MoleSense won support from H4 and CSEM.
Read More